Schedule 13G ownership disclosure

Inhibrx Biosciences Inc

Common Stock · CUSIP: 45720N103

Event date: 2025-12-31

Filing-level shares
768,130
Percent of class
5.3%
  • BlackRock, Inc.

    Shares: 768,130 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-26-000675
Form type
SCHEDULE 13G
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Jan 21, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub